WCG Investment Analysis Report & Stock Research, Wellcare Health Plans, Inc.

Wellcare Health Plans, Inc. (WCG)

WCG Stock Report

2-Year Price History

View Larger WCG Chart
NYSE:WCG
$30.29
(3/18 4:00PM)
+0.1%
Open$30.14 Mkt Cap$1.3 Billion
High$30.99 52Wk High$39.12
Low$30 52Wk Low$10.86
Volume676,603 Avg Vol 10D653,800

Ockham's Rating/Recommendation Summary

Rating specific information requires Premium Access.
Buy Now or Learn More about Ockham's Features and Services.

WCG Revenue

As a value investing shop, we are interested in seeing how WCG's revenues measure up against past performances. One easily understandable way of doing that is to compare Price to Sales per share levels over a given time frame. Assuming it is available, Ockham prefers to look at ten years of history (for this stock there are 7 years of history available) and we weigh recent years more heavily. This allows us to find weighted average historical high and low Price to Sales ratios, which give us a better idea of the stock's current underlying value. Using this method, we have established a high range for Price to Sales of 0.70x and the low end of the range at 0.22x.

With respect to these historically rational metrics, notice that the current Price to Sales per share ratio for WCG of 0.18x is well below its normal historic Price to Sales levels. At a price of $29.14, WCG is 62% below where we would expect to see it. Clearly, this stock looks undervalued compared to historical levels, at least on a Price to Sales basis. This will positively affect our analysis because it is rare to find a stock this far below historical norms, and we would expect some price appreciation to bring this metric back towards a more normal range.

WCG Cash Earnings

Looking at WCG specifically in their Cash Earnings capabilities, Ockham views WCG as significantly above its historical average multiple of cash earnings as calculated by Ockham. Similar to our analysis of sales per share, Ockham looks at the last 7 years of cash earnings levels for WCG to identify where the current high and low price levels have been historically in relation to profit per share. Again, we utilize a weighted average methodology which relies more heavily on recent years of data. This weighted average framework provides us with an average high Price to Cash Earnings ratio per share of 37.38 and a 10.56 low over the same period.

Therefore, at the current price of $29.14 and a Price to Cash Earnings ratio of 31.00, WCG is significantly overvalued. This diminishes the attractiveness of WCG until we see either a significant increase in cash earnings or a decline in price. A decline of the Price to Cash Earnings ratio of 29% is needed just to return to the historical cash earnings multiple.

WCG Dividends

A positive Ockham rating does not require a company to pay out an inviting dividend or a dividend at all. However, we believe dividends provide a useful measure of a company's inherent expectations. While we do like to see companies with healthy and growing dividends, it is not appropriate for all companies, especially those focused on growth. In this regard, we regard WCG as neutral because we do not have historical data for this company's dividends. We will being incorporating this into our analysis as soon as that data is available.

Peer Comparison

:

Wellcare Health Plans, Inc. Industry Grouping

(3/17/2010)
Company Ticker Market Cap (Ml) Latest
Price
Price/Cash Earnings Price/Sales 5-Yr. Rev.
Growth Rate
5-Yr.
Avg. ROE.
Current 10-Yr. Range* Current 10-Yr. Range*
Peer Company Averages (not including WCG) 11.94 5.65 » 55.00 1.84 0.83 » 4.73 16.29% 12.04%
*10 year range does not include current year values
American Medical Systems Holdings Inc. AMMD $1.4 Billion $19.02 11.80 5.22 » 145.60 2.82 1.18 » 7.07 19.99% 8.66%
Haemonetics Corp. HAE $1.4 Billion $56.16 13.28 6.88 » 21.01 2.26 1.12 » 3.43 10.42% 11.70%
West Pharmaceutical Services Inc WST $1.4 Billion $41.97 9.97 3.77 » 15.25 1.28 0.50 » 1.90 16.46% 13.72%
Chemed Corp. CHE $1.3 Billion $56.38 11.69 6.55 » 56.17 1.07 0.55 » 1.70 10.11% 14.70%
Wellcare Health Plans, Inc. WCG $1.3 Billion $30.25 31.00 4.00 » 41.64 0.18 0.04 » 1.00 37.58% 13.99%
Integra Lifesciences Holdings Corp. IART $1.3 Billion $43.72 12.95 5.84 » 36.98 1.76 0.79 » 9.56 24.46% 11.42%
Ockham Coverflow

Sharpen Your Investing

  • Access to over 5,000 stock reports
  • Portfolio Analytics and Tracking
  • Business Television Tracking
  • CNBC and Fox Business Show Recaps
Get Started
The Latest Financial News
The most recent Stocks on Financial TV & Blogs from impactful financial news sources
No commentary found for Commentary Missing
View All Wellcare Health Plans, Inc. Stock News

Key Fundamentals

WCG - Wellcare Health Plans, Inc. Fundamentals
Price (3/18 4:00PM) $30.29
Volume (3/18 4:00PM) 676,603
Last Close Price $30.25
10 Day Average Volume 653,800
13 Week Price Range $25.68 - $39.12
52 Week Price Range $10.86 - $39.12
LTM Revenue $6.9 Billion
 
Shares Outstanding (12/2009) 42.3 Million
Market Capitalization $1.3 Billion
Shares Held By Institutions 38.7 Million
Institutional Holders 209
% Shares Held By Institutions 91.30%
Earnings Per Share (EPS) $0.95
P/E Ratio 31.80
Book Value Per Share $20.80
 
Gross Margin n/a%
Annual Dividend 0.00
Dividend Yield 0.00%
Beta 2.11
Fiscal Year Ends December

About Wellcare Health Plans, Inc.

Wellcare Health Plans, Inc. is considered to operate in the Healthcare sector. They specifically operate in the Health Care Plans business segment contained within the Health Services industry.

The Company provides managed care services targeted exclusively to government-sponsored health care programs focused on Medicaid and Medicare, including prescription drug plans and health plans for families, children and the aged, blind and disabled.